Ordering a cocktail or a glass of wine (or three) when out to dinner can significantly inflate your bill. Consider getting ...

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

Pharma Tech Industries, a global provider of contract manufacturing and packaging solutions for pharmaceutical, medical ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

Being religious is a bit like learning to play soccer, says New York Times columnist and bestselling author Ross Douthat. You ...

Wells Fargo analyst Stephen Baxter maintained a Hold rating on Cencora (COR – Research Report) yesterday and set a price target of $251.00. The ...

The New York Times columnist and best-selling author hopes to convince spiritual seekers that faith in God might actually be ...

As third-party cookies disappear, video publishers face a stark reality. Without precise targeting and retargeting, their ad inventory risks becoming commoditized. For midsize players like FAST ...

Eric Le Berrigaud, an analyst from Stifel Nicolaus, maintained the Buy rating on Sanofi (SNYNF – Research Report). The associated price target ...

BofA Securities made adjustments to its financial model for Teva Pharmaceutical Industries Ltd (NYSE:TEVA), resulting in a lowered price target. While the firm maintained a Buy rating on the stock, ...

Teva Pharma Industries Ltd ADR (NYSE: TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line ...

The target audience is a critical factor to consider when ... Get ready to discover the dos and don'ts of effective brand naming! Generic names can lead to confusion among consumers, making it ...